YEWTF yields 2631.58% · JNJ yields 2.13%● Live data
📍 YEWTF pulled ahead of the other in Year 1
Combined, YEWTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YEWTF + JNJ for your $10,000?
Environmental Waste International Inc., together with its subsidiaries, designs and develops environmental products for waste treatment and disposal in Canada and the United States. It researches, designs, develops, sells, and maintains systems based on the patented Reverse Polymerization process and related delivery system. The company provides systems for feed tire reduction, biological wastewater sterilization, shipboard food waste sterilization/dehydration, and batch-based infectious medical waste sterilization. Its tire system breaks the molecular bonds in tires and other rubber products and reduces them to their base components of carbon black, steel, and hydrocarbon vapors. The company also offers FS-6000 and FS-POD biocontainment and wastewater sterilization units; MD-1000, a three-stage, three chamber, medical waste reduction unit that produces a sterilized carbon residue; and AW-1000 to process and reduce animal waste into its constituents. Environmental Waste International Inc. was incorporated in 1987 and is headquartered in Whitby, Canada.
Full YEWTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.